drugset / Trial / NCT00715871

Clinical Study of Smoke-Break Liquid Cigarettes

NCT00715871

Phase 2 Completed 52 enrolled Smoke-Break, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether the Smoke-Break nicotine delivery device can help smokers quit smoking, while avoiding many of the side effects associated with other smoking cessation products.

Timeline

Start
2008-02
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 1.5 mg

Indications

No indication recorded.